Abstract
Background: Enterobacteriaceae, the normal dwellers in the human intestine, are commonly associated with a variety of community-acquired and nosocomial infections. An emerging trend of antibiotic resistance among these strains is a notable issue globally; a more serious threat is the resistance against the available last resort antibiotics- the carbapenems.
Objective: The objective of our study was intended to determine the burden of resistance towards common antibiotic classes so as to address the gap of drug resistance prevalence data, among the Enterobacteriaceae isolates obtained from the health settings in this region. Methodology: A cross-sectional study was done with an inclusion of clinical isolates collected from varied sources from health settings in upper Assam. The isolates were identified based on standard methods of morphology study and biochemical tests. The identified isolates were then subjected to antibiotic susceptibility testing by following the Kirby-Bauer disc diffusion method, and the result was interpreted as per the CLSI guidelines. The resistance of the reported carbapenem-resistant isolates was confirmed by minimum inhibitory concentration (MIC) determination using a commercial E-strip kit. Results: Among the enterobacterial isolates Klebsiella spp. accounted for the majority, followed by Escherichia coli, Citrobacter spp., Shigella spp. and others. Multi-drug resistance (MDR) was noted among 67.6% isolates; however, carbapenem resistance was confirmed in 18.9% of the total Enterobacteriaceae isolates. Conclusion: Higher prevalence of resistance towards carbapenems, among the Enterbacteriaceae isolates of upper Assam seems to be an upcoming threat to the region, limiting the treatment options in the future.Keywords: Carbapenem, resistance, Enterobacteriaceae, north-east India, MDR, gram-negative bacteria.
Graphical Abstract
Anti-Infective Agents
Title:Carbapenem Resistance Among Common Enterobacteriaceae Clinical Isolates in Part of North-East India
Volume: 19 Issue: 4
Author(s): Mohan Sharma, Pankaj Chetia*, Minakshi Puzari, Nakul Neog, Upasana Phukan and Amrit Borah
Affiliation:
- Department of Life Sciences, Dibrugarh University, Dibrugarh- 786004, Assam,India
Keywords: Carbapenem, resistance, Enterobacteriaceae, north-east India, MDR, gram-negative bacteria.
Abstract: Background: Enterobacteriaceae, the normal dwellers in the human intestine, are commonly associated with a variety of community-acquired and nosocomial infections. An emerging trend of antibiotic resistance among these strains is a notable issue globally; a more serious threat is the resistance against the available last resort antibiotics- the carbapenems.
Objective: The objective of our study was intended to determine the burden of resistance towards common antibiotic classes so as to address the gap of drug resistance prevalence data, among the Enterobacteriaceae isolates obtained from the health settings in this region. Methodology: A cross-sectional study was done with an inclusion of clinical isolates collected from varied sources from health settings in upper Assam. The isolates were identified based on standard methods of morphology study and biochemical tests. The identified isolates were then subjected to antibiotic susceptibility testing by following the Kirby-Bauer disc diffusion method, and the result was interpreted as per the CLSI guidelines. The resistance of the reported carbapenem-resistant isolates was confirmed by minimum inhibitory concentration (MIC) determination using a commercial E-strip kit. Results: Among the enterobacterial isolates Klebsiella spp. accounted for the majority, followed by Escherichia coli, Citrobacter spp., Shigella spp. and others. Multi-drug resistance (MDR) was noted among 67.6% isolates; however, carbapenem resistance was confirmed in 18.9% of the total Enterobacteriaceae isolates. Conclusion: Higher prevalence of resistance towards carbapenems, among the Enterbacteriaceae isolates of upper Assam seems to be an upcoming threat to the region, limiting the treatment options in the future.Export Options
About this article
Cite this article as:
Sharma Mohan , Chetia Pankaj *, Puzari Minakshi , Neog Nakul , Phukan Upasana and Borah Amrit , Carbapenem Resistance Among Common Enterobacteriaceae Clinical Isolates in Part of North-East India, Anti-Infective Agents 2021; 19 (4) : e130621190844 . https://dx.doi.org/10.2174/2211352519999210128174853
DOI https://dx.doi.org/10.2174/2211352519999210128174853 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mortality and Morbidity of HIV Infected Patients Receiving HAART: A Cohort Study
Current HIV Research Rethinking the Excitotoxic Ionic Milieu:The Emerging Role of Zn 2+ in Ischemic Neuronal Injury
Current Molecular Medicine Diagnosis and Treatment of Pulmonary Fungal Infections in Critically Ill Patients
Current Respiratory Medicine Reviews An Update on the Xenograft and Mouse Models Suitable for Investigating New Therapeutic Compounds for the Treatment of B-Cell Malignancies
Current Pharmaceutical Design Biologics for ANCA-Associated Vasculitis
Inflammation & Allergy - Drug Targets (Discontinued) Separating Fact from Fiction: The Data Behind Allergies and Side Effects Caused by Penicillins, Cephalosporins, and Carbapenem Antibiotics
Current Pharmaceutical Design Biology of gama delta T Cells in Tuberculosis and Malaria
Current Molecular Medicine Minocycline and Doxycycline: More Than Antibiotics
Current Molecular Pharmacology New Strategies and Patent Therapeutics in EBV-Associated Diseases
Mini-Reviews in Medicinal Chemistry Nanotools for the Delivery of Antimicrobial Peptides
Current Drug Targets Microsomal Prostaglandin E Synthase: A Key Enzyme in PGE2 Biosynthesis and Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Passive Immunization as Tool to Identify Protective HIV-1 Env Epitopes
Current HIV Research Conformational Flexibility in Designing Peptides for Immunology: The Molecular Dynamics Approach
Current Computer-Aided Drug Design Characterization of a Bacteriophage-Derived Murein Peptidase for Elimination of Antibiotic-Resistant Staphylococcus aureus
Current Protein & Peptide Science Abeta DNA Vaccination for Alzheimers Disease: Focus on Disease Prevention
CNS & Neurological Disorders - Drug Targets JNK Signalling: A Possible Target to Prevent Neurodegeneration
Current Pharmaceutical Design Structure and Functions of Bacterial Outer Membrane Protein A, A Potential Therapeutic Target for Bacterial Infection
Current Topics in Medicinal Chemistry Lignans and Neolignans Anti-tuberculosis Identified by QSAR and Molecular Modeling
Combinatorial Chemistry & High Throughput Screening Analysis of Adverse Events Related to 720 Cases of Neural Progenitor Cell Transplantation
CNS & Neurological Disorders - Drug Targets Post Dural Puncture Headache and Hypertension
Current Hypertension Reviews